The intravenous solutions market was valued at USD 18.1 billion in 2025. Grand View Research projects it will reach USD 28.7 billion by 2033, a CAGR of 5.8% from 2026 to 2033. The 2026 estimate is USD 19.3 billion. North America led with a 41.8% revenue share in 2025, and the U.S. was the largest country market. Market Overview: Why Demand for IV Fluids Keeps Rising Intravenous (IV) solutions...